ArticleArthritis research & therapy2017

Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.

Jérémie Sellam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.